{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_005624.4:c.160G>T",
          "cDNA Change": {
            "transcript": "NM_005624.4",
            "ref": "G",
            "alt": "T",
            "position": "160"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "mutant A53T α-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0004976"
  },
  "Experiment Method": [
    {
      "Assay Method": "Macroautophagy activation and mitochondrial destruction analysis",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "Primary cortical neurons overexpressing mutant A53T α-synuclein",
        "Description": "The experiment was conducted using primary cortical neurons that overexpress mutant A53T α-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_005624.4:c.160G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The activation of macroautophagy led to mitochondrial destruction and dysfunction in neurons overexpressing mutant A53T α-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Silencing Parkin or overexpressing wild-type Mitofusin 2 were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal mitochondrial content and function, as determined by fluorescence microscopy or flow cytometry.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant reduction in mitochondrial content or dysfunction observed via fluorescence microscopy or flow cytometry.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}